Ocugen, Bharat Biotech sign agreement for commercialisation rights to COVAXIN in Canada EP News Bureau Jun 3, 2021 Similar to the US profit share arrangement, Ocugen will retain 45 per cent of the profits from sales of COVAXIN in Canada
